Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-12-26
2006-12-26
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C530S350000, C530S408000, C530S409000, C530S410000
Reexamination Certificate
active
07153836
ABSTRACT:
A hedgehog conjugate which is characterized in that it contains: a) a polypeptide composed of 10 to 30 hydrophobic amino acids and/or amino acids which form transmembrane helices and are positively charged, b) 1 to 4 aliphatic, saturated or unsaturated hydrocarbon residues with a chain length of 10 to 24 C atoms and with a hydrophobic action or c) a hydrophobic thio compound covalently bound to a hedgehog protein and which has a several-fold increased activity and is suitable as a pharmaceutical agent.
REFERENCES:
patent: 5364839 (1994-11-01), Gerhart et al.
patent: 5700774 (1997-12-01), Hattersley et al.
patent: 5844079 (1998-12-01), Ingham et al.
patent: 6207718 (2001-03-01), Papadimitriou
patent: 6444793 (2002-09-01), Pepinsky et al.
patent: 6468978 (2002-10-01), Esswein et al.
patent: 6818623 (2004-11-01), Esswein et al.
patent: 6897297 (2005-05-01), Pepinsky et al.
patent: 6994990 (2006-02-01), Lang et al.
patent: WO 92/09697 (1992-06-01), None
patent: WO 95/18856 (1995-07-01), None
patent: WO 96/16668 (1996-06-01), None
patent: WO 98/02454 (1998-01-01), None
patent: WO 98/30576 (1998-07-01), None
Farese, R.V. et al. Trends in Genetics 14, 115-120 (Mar. 1998).
Hammerschmidt et al. Trends in Genetics 13, 14-21 (Jan. 1997).
Hancock, J.F. et al. Cell 63, 133-139 (Oct. 1990).
Hynes, M. et al. Neuron 15, 35-44 (Jul. 1995).
Mohler, J. et al. Development 115, 957-971 (1992).
Nakamura, T. et al. Biochem. Biophys. Res. Comm. 237, 465-469 (1997).
Pepinsky, R.B. et al. J. Biol. Chem. 273, 14037-14045 (May 1998).
Porter, J.A. et al. Cell 86, 21-34 (Jul. 1996).
Porter, J.A. et al. Science 274, 255-259 (Oct. 1996).
Seytter, T. et al. Bone 23, Abstract Sa151 (Nov. 1998).
Kinto, N. et al., Fibroblasts Expressing Sonic Hedgehog Induce Osteoblast Differentiation and Ectopic Bone Formation:, FEBS Letters, 404: 319-323 (1997).
Vukicevic, S. et al., “Discovery and Clinical Applications of Bone Morphogenetic Proteins”, European Journal of Clinical Chemistry and Clinical Biochemistry, 33:(10), 661-671 (1995).
Esswein Angelika
Lang Kurt
Rueger Petra
Seytter Tilmann
Curis, Inc.
Fish & Neave IP Group Ropes & Gray LLP
Russel Jeffrey Edwin
LandOfFree
Active hedgehog protein conjugate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Active hedgehog protein conjugate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Active hedgehog protein conjugate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3690932